TAS 2021 10th Annual Toledo Allergy Society Conference
It is an exciting time in the field of allergy and immunology. This CME program is designed to allow attendees to continue exploring the Immunology Frontier. Covered topics include current and emerging treatments in angioedema, immunodeficiency and food allergy.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
Upon completion of this activity the participant should be able to:
- Review diagnosis and treatment of different types of angioedema and prioritize steroid sparing treatment options for patients with chronic urticaria
- Recommend early food introduction based on current guidelines for prevention of food allergies
Michael Blaiss, MD
Consultant: Pfizer, Merck, Hycor, ALK, Greer, Sanofi, JDP, PMD, DBV
Timothy Craig, DO
Speaker: CSL Behring, Biocryst, Pharming
Consultant: Takeda, Ionis
Alan Baptist, MD, MPH
Researcher: AstraZeneca , Novartis, Takeda
James Baldwin, MD
Healgen Scientific LLC, Researcher, consulting fees
Access Bio, INC, Researcher, consulting fees
Discovery Research FFMI, Researcher. Consulting fees
Regeneron, Researcher, consulting fees
Anna Kovalszki, MD
Speaker: GSK
The following have no relevant financial relationships to disclose:
Jung Yi Sun, MD
Deborah Lee, MD
Marisa Hodges, MD
Ruchi Gupta, MD
M. Razi Rafeeq, MD
Svetlana Kriegel, MD
Julie Hemminger
Available Credit
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Attendance